Diovan Issue　is “Isolated Example,” Confidence in Japan Clinical Trials Not Lost: President Viehbacher of EFPIA

Christopher Viehbacher, President of EFPIA Speaking with reporters in Tokyo on October 3, Christopher Viehbacher (Chief Executive Officer, Sanofi S.A. of France), president of the European Federation of Pharmaceutical Industries and Associations (EFPIA), said that the EFPIA does not plan...read more